Skip to main content
SpringerLink
Log in

Very late-phase vascular response after everolimus-eluting stent implantation assessed by optical coherence tomography

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

Long-term safety of second generation drug-eluting stents (DES) has not yet been evaluated. We sought to evaluate the very late phase (> 3 years) vascular response after second generation everolimus-eluting stent (EES) as compared with first generation sirolimus-eluting stent (SES) by using optical coherence tomography (OCT). We examined the vascular response in 39 patients with a total of 55 DESs [31 EESs (mean 54 months after stenting) and 24 first generation SES (mean 66 months after stenting)] by OCT. The frequency of lesions with any malapposed stent struts (19% vs. 46%, p = 0.035) and evagination (6% vs. 42%, p = 0.002) was significantly lower. Segments with malapposed stent struts were significantly shorter (0.4 ± 0.9 mm vs. 1.9 ± 3.5 mm, p = 0.024), maximal malapposition area and malapposition volume were significantly smaller (0.26 ± 0.38 mm2 vs. 0.95 ± 1.54 mm2, p = 0.019, and 0.78 ± 1.35 mm3 vs. 6.22 ± 15.76 mm3, p = 0.016, respectively) in EES. Compared with first generation SES, second generation EES showed more favourable vascular responses at the very late phase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, RAVEL Study Group et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780

    Article  CAS  Google Scholar 

  2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, SIRIUS Investigators et al (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315–1323

    Article  CAS  Google Scholar 

  3. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G et al (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369:667–678

    Article  CAS  Google Scholar 

  4. Kuriyama N, Kobayashi Y, Nakama T, Mine D, Nishihira K, Shimomura M, Nomura K, Ashikaga K, Matsuyama A, Shibata Y (2011) Late restenosis following sirolimus-eluting stent implantation. JACC Cardiovasc Interv 4:123–128

    Article  Google Scholar 

  5. Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, Gold HK, Burke AP, Kolodgie FD, Virmani R (2008) Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 118:1138–1145

    Article  Google Scholar 

  6. Nakazawa G, Finn AV, Vorpahl M, Ladich ER, Kolodgie FD, Virmani R (2011) Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents. J Am Coll Cardiol 57:390–398

    Article  CAS  Google Scholar 

  7. Taniwaki M, Radu MD, Zaugg S, Amabile N, Garcia-Garcia HM, Yamaji K, Jørgensen E, Kelbæk H, Pilgrim T, Caussin C et al (2016) Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography. Circulation 133:650–660

    Article  CAS  Google Scholar 

  8. Guagliumi G, Sirbu V, Musumeci G, Gerber R, Biondi-Zoccai G, Ikejima H, Ladich E, Lortkipanidze N, Matiashvili A, Valsecchi O et al (2012) Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc Interv 5:12–20

    Article  Google Scholar 

  9. Otsuka F, Byrne RA, Yahagi K, Mori H, Ladich E, Fowler DR, Kutys R, Xhepa E, Kastrati A, Virmani R et al (2015) Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J36:2147–2159

    Article  Google Scholar 

  10. Park SJ, Kang SJ, Virmani R, Nakano M, Ueda Y (2012) In-stent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol 59:2051–2057

    Article  Google Scholar 

  11. Ino Y, Kubo T, Kameyama T, Shimamura K, Terada K, Matsuo Y, Kitabata H, Shiono Y, Kashiwagi M, Kuroi A et al (2018) Clinical utility of combined optical coherence tomography and near-infrared spectroscopy for assessing the mechanism of very late stent thrombosis. JACC Cardiovasc Imaging 11:772–775

    Article  Google Scholar 

  12. Giglioli C, Formentini C, Romano SM, Cecchi E, Baldereschi GJ, Landi D, Chiostri M, Prati F, Marchionni N (2019) Vulnerable struts with CRE8, Biomatrix and Xience stents assessed with OCT and their correlation with clinical variables at 6-month follow-up: the CREBX-OCT study. Int J Cardiovasc Imaging. https://doi.org/10.1007/s10554-019-01719-1

    Article  PubMed  Google Scholar 

  13. Sabate M, Cequier A, Iñiguez A, Serra A, Hernandez-Antolin R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A et al (2012) Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomized controlled trial. Lancet 380:1482–1490

    Article  CAS  Google Scholar 

  14. Ino Y, Kubo T, Tanaka A, Liu Y, Tanimoto T, Kitabata H, Shiono Y, Shimamura K, Orii M, Komukai K et al (2015) Comparison of vascular response between everolimus-eluting stent and bare metal stent implantation in ST-segment elevation myocardial infarction assessed by optical coherence tomography. Eur Heart J Cardiovasc Imaging 16:513–520

    Article  Google Scholar 

  15. Dangas GD, Serruys PW, Kereiakes DJ, Hermiller J, Rizvi A, Newman W, Sudhir K, Smith RS Jr, Cao S, Theodoropoulos K et al (2013) Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (clinical evaluation of the Xience V everolimus-eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions). JACC Cardiovasc Interv 6:914–922

    Article  Google Scholar 

  16. Usui E, Yonetsu T, Kanaji Y, Hoshino M, Yamaguchi M, Hada M, Hamaya R, Kanno Y, Murai T, Lee T et al (2018) Prevalence of neoatherosclerosis in sirolimus-eluting stents in a very late phase after implantation. EuroIntervention. https://doi.org/10.4244/EIJ-D-18-00486

    Article  PubMed  Google Scholar 

  17. Ino Y, Kubo T, Matsuo Y, Yamaguchi T, Shiono Y, Shimamura K, Katayama Y, Nakamura T, Aoki H, Taruya A et al (2016) Optical coherence tomography predictors for edge restenosis after everolimus-eluting stent implantation. Circ Cardiovasc Interv 9:e004231

    Article  CAS  Google Scholar 

  18. Uchimura Y, Itoh T, Oda H, Taguchi Y, Sasaki W, Kaneko K, Sakamoto T, Goto I, Sakuma M, Ishida M et al (2019) Cut-off value of mal-apposition volume and depth for resolution at early phase of acute incomplete stent apposition after CoCr-EES implantation. Int J Cardiovasc Imaging 35:1979–1987

    Article  Google Scholar 

  19. Galløe AM, Kelbæk H, Thuesen L, Hansen HS, Ravkilde J, Hansen PR, Christiansen EH, Abildgaard U, Stephansen G, Lassen JF, SORT OUT II Investigators et al (2017) 10 year clinical outcome after randomization to treatment by sirolimus- or paclitaxel-eluting coronary stents. J Am Coll Cardiol 69:616–624

    Article  Google Scholar 

  20. Takano M, Yamamoto M, Mizuno M, Murakami D, Inami T, Kimata N, Murai K, Kobayashi N, Okamatsu K, Ohba T (2010) Late vascular responses from 2 to 4 years after implantation of sirolimus-eluting stents: serial observations by intracoronary optical coherence tomography. Circ Cardiovasc Interv 3:476–483

    Article  CAS  Google Scholar 

  21. Kubo T, Akasaka T, Kozuma K, Kimura K, Kawamura M, Sumiyoshi T, Ino Y, Morino Y, Tanabe K, Kadota K, RESET Investigators et al (2015) Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (randomized evaluation of sirolimus-eluting versus everolimus-eluting stent trial). EuroIntervention 11:564–571

    Article  Google Scholar 

  22. Katayama Y, Kubo T, Akasaka T, Ino Y, Kimura K, Okura H, Shinke T, Igarashi K, Kadota K, Kozuma K, NEXT investigators et al (2017) Two-year vascular responses to drug-eluting stents with biodegradable polymer versus durable polymer: an optical coherence tomography sub-study of the NEXT. J Cardiol 70:530–536

    Article  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama, 641-8509, Japan

    Amir Kh. M. Khalifa, Yasushi Ino, Takashi Kubo, Takashi Tanimoto, Kunihiro Shimamura, Yasutsugu Shiono, Masahiro Takahata, Kosei Terada, Daisuke Higashioka, Teruaki Wada, Akira Taruya, Hiroki Emori, Yosuke Katayama, Manabu Kashiwagi, Akio Kuroi, Yoshiki Matsuo, Suwako Fujita, Atsushi Tanaka, Takeshi Hozumi & Takashi Akasaka

Authors
  1. Amir Kh. M. Khalifa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yasushi Ino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takashi Kubo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Tanimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kunihiro Shimamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yasutsugu Shiono
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masahiro Takahata
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kosei Terada
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Daisuke Higashioka
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Teruaki Wada
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Akira Taruya
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Hiroki Emori
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Yosuke Katayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Manabu Kashiwagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Akio Kuroi
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Yoshiki Matsuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Suwako Fujita
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Atsushi Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Takeshi Hozumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Takashi Akasaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasushi Ino.

Ethics declarations

Conflict of interest

Dr. Kubo has received lecture fees from Abbott Vascular and Terumo. Dr. Akasaka has received lecture fees from Abbott Vascular and Terumo, and research grants from Abbott Vascular and Terumo. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khalifa, A.K.M., Ino, Y., Kubo, T. et al. Very late-phase vascular response after everolimus-eluting stent implantation assessed by optical coherence tomography. Int J Cardiovasc Imaging 36, 1627–1635 (2020). https://doi.org/10.1007/s10554-020-01877-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-020-01877-7

Keywords

Search

Navigation